Melanie Komadoski is a seasoned marketing leader with a deep understanding of the pharmaceutical landscape in Canada. In her current role as the Marketing Director for Established Brands at Viatris, she oversees a portfolio of trusted, high-equity products – including EpiPen, Viagra, and Lipitor – that contribute to the 1.45 billion doses Viatris delivers to Canadians each year.
With nearly a decade of experience launching products across allergy, gastroenterology, and oncology biosimilars, Melanie is now focused on shaping loss-of-exclusivity strategy and maximizing the long-term value of established brands. Her background spans both public and private sector, giving her unique insight into how to connect science, policy, and patient voices in impactful ways.
Melanie’s passion for patient-centered care is rooted in her earlier work with patient advocacy groups and further demonstrated through her leadership in launching patient support programs for biosimilars. This uniquely positions her to bring a thoughtful, patient-centric lens to Viatris’ marketing programs.
She holds a Bachelor of Science in Neuropsychology and a Master of Science in Neurobiology from Brock University.
Day 1: Oct 15, 2025
2:45 pm
FIRESIDE CHAT
Driving Team Collaboration Across Sales, Marketing, and Operations
Boost overall organizational performance by fostering a culture of collaboration among marketing, sales, and operations. Achieve a step-by-step action plan to:
- Recognize the importance of cross-functional collaboration.
- Identify barriers to effective teamwork between sales, marketing, and operations.
- Develop strategies to enhance communication and alignment.
Bolster your culture of collaboration to improve coordination, decision-making, and cross-departmental relationships.
Day 2: Oct 15, 2025
10:00 am
FIRESIDE CHAT
Understanding the Patient Perspective: What Do they Want from Pharma and Biotech Companies?
Deepen your understanding of the patient perspective and their expectations from pharmaceutical and biotech companies. Source practical tips to:
- Explore what patients value most from pharma and biotech companies, including transparency, personalized care, and accessible information.
- Discuss how companies can integrate patient feedback into their drug development, marketing, and support strategies.
- Highlight real-world examples of patient-centric initiatives that have resonated with communities and extract lessons learned from past challenges.
Improve your understanding of the patient voice and how to shape strategies that prioritize their needs, build trust, and encourage long-term loyalty.
